NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT00900302 2016-02-10OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerOHSU Knight Cancer InstituteCompleted98 enrolled